AbbVie (ABBV) Other Non Operating Income (2012 - 2026)

AbbVie (ABBV) has reported Other Non Operating Income for 15 consecutive years, with -$1.5 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non Operating Income rose 44.59% year-over-year to -$1.5 billion in Q2 2026; TTM through Jun 2026 was -$5.5 billion, a 1.44% decrease from a year earlier, with the FY2025 full-year figure at -$5.8 billion, down 78.8% from the prior year.
• Other Non Operating Income was -$1.5 billion for Q2 2026 at AbbVie, up from -$2.3 billion in the prior quarter.
• Over five years, Other Non Operating Income peaked at $776.0 million in Q1 2022 and troughed at -$2.7 billion in Q2 2025.
• A 5-year average of -$1.1 billion and a median of -$1.4 billion in 2023 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income surged 1671.43% in 2022 and slumped 1320.0% in 2024, its largest moves.
• Over 5 years, Other Non Operating Income stood at -$2.0 billion in 2022, then grew by 23.01% to -$1.6 billion in 2023, then surged by 90.36% to -$150.0 million in 2024, then slumped by 706.67% to -$1.2 billion in 2025, then dropped by 21.9% to -$1.5 billion in 2026.
• The last three Other Non Operating Income figures came in at -$1.5 billion (Q2 2026), -$2.3 billion (Q1 2026), and -$1.2 billion (Q4 2025), per Business Quant data.